EP0673240B1
(en)
*
|
1992-12-09 |
1999-03-24 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Stabilized medicinal aerosol solution formulations
|
AU4655596A
(en)
*
|
1995-01-17 |
1996-08-07 |
Omega Pharmaceutical, Incorporated |
Liquid stable vitamin c compositions and delivery systems, and methods of making and uses thereof
|
US5653961A
(en)
*
|
1995-03-31 |
1997-08-05 |
Minnesota Mining And Manufacturing Company |
Butixocort aerosol formulations in hydrofluorocarbon propellant
|
ATE219934T1
(de)
*
|
1995-04-14 |
2002-07-15 |
Smithkline Beecham Corp |
Dosierinhalator für albuterol
|
CZ288337B6
(en)
*
|
1995-06-27 |
2001-05-16 |
Boehringer Ingelheim Kg |
Pharmaceutical preparation
|
DE19528145A1
(de)
*
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
US20030215396A1
(en)
|
1999-09-15 |
2003-11-20 |
Boehringer Ingelheim Pharma Kg |
Method for the production of propellant gas-free aerosols from aqueous medicament preparations
|
DE19653969A1
(de)
*
|
1996-12-20 |
1998-06-25 |
Boehringer Ingelheim Kg |
Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
|
ATE357214T1
(de)
|
1996-12-30 |
2007-04-15 |
Battelle Memorial Institute |
Verwendung eines unverkapselten anti-krebs- wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation
|
CZ296966B6
(cs)
*
|
1997-02-24 |
2006-08-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Farmaceutický prostredek
|
GB2326334A
(en)
*
|
1997-06-13 |
1998-12-23 |
Chiesi Farma Spa |
Pharmaceutical aerosol compositions
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
WO1999045777A1
(en)
*
|
1998-03-10 |
1999-09-16 |
The Children's Hospital Of Philadelphia |
Compositions and methods for treatment of asthma
|
CN1161104C
(zh)
*
|
1998-06-18 |
2004-08-11 |
贝林格尔·英格海姆药物公司 |
有二种或多种活性物质的气溶胶药物制剂
|
DE19847968A1
(de)
*
|
1998-10-17 |
2000-04-20 |
Boehringer Ingelheim Pharma |
Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
GB9902689D0
(en)
*
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
DE19921693A1
(de)
*
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
EP1143930B8
(en)
|
1999-09-11 |
2008-03-19 |
Glaxo Group Limited |
Pharmaceutical formulation of fluticasone propionate
|
AU2206801A
(en)
*
|
1999-12-24 |
2001-07-09 |
Alan Leslie Cripps |
Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
IT1317846B1
(it)
*
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
IT1318514B1
(it)
*
|
2000-05-12 |
2003-08-27 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
|
DZ3358A1
(fr)
|
2000-05-22 |
2001-11-29 |
Chiesi Farma Spa |
Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
|
TR200402579T4
(tr)
*
|
2000-10-12 |
2004-12-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Kristalin monohidrat, bunun imalat yöntemi ve bir ilaç maddesinin imalatında kullanımı
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
DE10063957A1
(de)
*
|
2000-12-20 |
2002-06-27 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten
|
US6620438B2
(en)
*
|
2001-03-08 |
2003-09-16 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
|
US20020085978A1
(en)
*
|
2000-11-10 |
2002-07-04 |
Mina Buenafe |
Degradation-resistant glucocorticosteroid formulations
|
US20100310477A1
(en)
*
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
EP1241113A1
(en)
|
2001-03-12 |
2002-09-18 |
CHIESI FARMACEUTICI S.p.A. |
Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
|
DE10111843A1
(de)
*
|
2001-03-13 |
2002-09-19 |
Boehringer Ingelheim Pharma |
Verbindungen zur Behandlung von inflammatorischen Erkrankungen
|
US6455028B1
(en)
|
2001-04-23 |
2002-09-24 |
Pharmascience |
Ipratropium formulation for pulmonary inhalation
|
US20050070487A1
(en)
*
|
2001-04-24 |
2005-03-31 |
Nyce Jonathan W. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
DK1273292T3
(da)
|
2001-07-02 |
2004-10-04 |
Chiesi Farma Spa |
Optimeret tobramycinformulering til aerosoldannelse
|
DE10135355C1
(de)
*
|
2001-07-20 |
2003-04-17 |
Schering Ag |
Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie
|
KR100810872B1
(ko)
|
2001-09-18 |
2008-03-06 |
니코메드 덴마크 에이피에스 |
감기 치료용 조성물
|
US20030191151A1
(en)
*
|
2001-10-26 |
2003-10-09 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
WO2003037317A1
(en)
*
|
2001-10-26 |
2003-05-08 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
US20030140920A1
(en)
*
|
2001-10-26 |
2003-07-31 |
Dey L.P. |
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
US20030203930A1
(en)
*
|
2001-10-26 |
2003-10-30 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
AU3297402A
(en)
*
|
2001-10-26 |
2003-10-30 |
Dey, L.P. |
An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
US8084461B2
(en)
|
2001-10-26 |
2011-12-27 |
Dey, L.P. |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
DE10161368A1
(de)
*
|
2001-12-14 |
2003-07-10 |
Messer Griesheim Gmbh |
Vorrichtung und Verfahren zum kryogenen Abfüllen von Aerosol-Produktansätzen
|
US20030147814A1
(en)
*
|
2001-12-21 |
2003-08-07 |
3M Innovative Properties Company |
Medicinal aerosol formulations comprising ion pair complexes
|
ATE406152T1
(de)
|
2001-12-21 |
2008-09-15 |
3M Innovative Properties Co |
Medizinische aerosolzusammensetzungen mit einer eine amid- und/oder estergruppe enthaltenden exzipientenverbindung
|
DE60231428D1
(de)
|
2001-12-21 |
2009-04-16 |
3M Innovative Properties Co |
Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff
|
JP2005523905A
(ja)
*
|
2002-03-01 |
2005-08-11 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
ホルモテロール(formoterol)超微細調合物
|
US20040126325A1
(en)
*
|
2002-03-12 |
2004-07-01 |
David Lewis |
Medicinal aerosol solution formulation products with improved chemical stability
|
US7244415B2
(en)
|
2002-03-28 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations of an anhydrate
|
US7311894B2
(en)
*
|
2002-03-28 |
2007-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations containing an anticholinergic
|
WO2003099207A2
(en)
*
|
2002-05-24 |
2003-12-04 |
Agennix Incorporated |
Oral lactoferrin in the treatment of respiratory disorders
|
KR20060011783A
(ko)
*
|
2002-06-12 |
2006-02-03 |
에피제네시스 파마슈티칼스 아이엔씨 |
데하이드로에피안드로스테론 스테로이드 및항-무스카린제와 더불어 호흡기 및 폐 질환을 치료하기위한 조성물, 제제 및 키트
|
US7056916B2
(en)
*
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
EP1575588A1
(en)
*
|
2002-12-16 |
2005-09-21 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Tiotropium containing hfc solution formulations
|
US20050058606A1
(en)
*
|
2002-12-16 |
2005-03-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing HFC solution formulations
|
EP1915985A1
(en)
*
|
2003-03-20 |
2008-04-30 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
|
AU2004224367B2
(en)
*
|
2003-03-20 |
2009-10-08 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
|
US7273603B2
(en)
*
|
2003-07-11 |
2007-09-25 |
Boehringer Ingelheim International Gmbh |
HFC solution formulations containing an anticholinergic
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
US20050101545A1
(en)
*
|
2003-07-31 |
2005-05-12 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
US20090317476A1
(en)
*
|
2003-07-31 |
2009-12-24 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
US20050026882A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
US20050038004A1
(en)
*
|
2003-07-31 |
2005-02-17 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
AR041873A1
(es)
*
|
2003-10-30 |
2005-06-01 |
Pablo Cassara Srl Lab |
Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
|
EP1595531A1
(en)
*
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
KR20070000476A
(ko)
*
|
2004-02-27 |
2007-01-02 |
키에시 파르마슈티시 엣스. 피. 에이. |
압축화 계량된 도스흡입용 안정된 약제용액 제제
|
US7220742B2
(en)
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
US20050255050A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Powder formulations for inhalation, comprising enantiomerically pure beta agonists
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
JP5209963B2
(ja)
|
2004-07-02 |
2013-06-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
噴霧剤としてtg227ea又はtg134aを含有するエアロゾル懸濁製剤
|
GB0501956D0
(en)
*
|
2005-01-31 |
2005-03-09 |
Arrow Internat |
Nebulizer formulation
|
WO2006089656A2
(en)
|
2005-02-25 |
2006-08-31 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
|
JP2008538758A
(ja)
*
|
2005-04-23 |
2008-11-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
|
DK1881980T3
(da)
|
2005-05-02 |
2012-10-01 |
Boehringer Ingelheim Int |
Nye krystalline former af tiotropiumbromid
|
CN101208316B
(zh)
*
|
2005-08-15 |
2012-05-09 |
贝林格尔·英格海姆国际有限公司 |
制备β-模拟物的方法
|
WO2007034207A2
(en)
*
|
2005-09-25 |
2007-03-29 |
Cipla Limited |
Troventol formulation
|
US20070086957A1
(en)
*
|
2005-10-10 |
2007-04-19 |
Thierry Bouyssou |
Combination of medicaments for the treatment of respiratory diseases
|
US20070088030A1
(en)
*
|
2005-10-10 |
2007-04-19 |
Barbara Niklaus-Humke |
Aerosol formulations for the inhalation of beta-agonists
|
DE102006017320A1
(de)
|
2006-04-11 |
2007-10-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
|
DE102006023770A1
(de)
*
|
2006-05-20 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Treibgasfreie Aerosolformulierung für die Inhalation
|
WO2008008494A2
(en)
*
|
2006-07-13 |
2008-01-17 |
Accentia Biopharmaceuticals, Inc. |
Methods and compositions for treating mucosal inflammation
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2201934A1
(en)
|
2008-12-23 |
2010-06-30 |
CHIESI FARMACEUTICI S.p.A. |
Tiotropium aerosol formulation products with improved chemical stability
|
EP2414560B1
(de)
|
2009-03-31 |
2013-10-23 |
Boehringer Ingelheim International GmbH |
Verfahren zur beschichtung einer oberfläche eines bauteils
|
JP5763053B2
(ja)
|
2009-05-18 |
2015-08-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
アダプタ、吸入器具及びアトマイザ
|
DK2501363T3
(en)
|
2009-11-17 |
2015-03-23 |
Cipla Ltd |
inhalable
|
JP5658268B2
(ja)
|
2009-11-25 |
2015-01-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
CN102686260B
(zh)
|
2009-11-25 |
2014-10-01 |
贝林格尔.英格海姆国际有限公司 |
喷雾器
|
WO2011084316A2
(en)
|
2009-12-16 |
2011-07-14 |
3M Innovative Properties Company |
Formulations and methods for controlling mdi particle size delivery
|
MX340264B
(es)
|
2009-12-23 |
2016-07-04 |
Chiesi Farm Spa |
Formulacion de aerosol para la enfermedad pulmonar obstructiva cronica.
|
PE20160853A1
(es)
*
|
2009-12-23 |
2016-09-14 |
Chiesi Farm Spa |
Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc)
|
JP5874724B2
(ja)
|
2010-06-24 |
2016-03-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
JP5409594B2
(ja)
*
|
2010-12-22 |
2014-02-05 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
加圧式定量吸入器のための安定な製薬学的溶液製剤
|
US20120204871A1
(en)
*
|
2011-02-10 |
2012-08-16 |
Julio Cesar Vega |
Stable, non-corrosive formulations for pressurized metered dose inhalers
|
WO2012130757A1
(de)
|
2011-04-01 |
2012-10-04 |
Boehringer Ingelheim International Gmbh |
Medizinisches gerät mit behälter
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
GB201200504D0
(en)
|
2011-12-19 |
2012-02-22 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhaler
|
GB201200525D0
(en)
|
2011-12-19 |
2012-02-29 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhalable medicament
|
WO2013127738A1
(de)
|
2012-02-28 |
2013-09-06 |
Boehringer Ingelheim International Gmbh |
Neue treibgashaltige tiotropium-formulierung
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
RU2496477C1
(ru)
*
|
2012-09-20 |
2013-10-27 |
Шолекс Девелопмент Гмбх |
Раствор ипратропия бромида
|
JP6643231B2
(ja)
|
2013-08-09 |
2020-02-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
PL2835146T3
(pl)
|
2013-08-09 |
2021-04-06 |
Boehringer Ingelheim International Gmbh |
Nebulizator
|
RU2536253C1
(ru)
*
|
2013-10-09 |
2014-12-20 |
Шолекс Девелопмент Гмбх |
Комбинированный аэрозольный препарат для лечения болезней органов дыхания
|
PL2897588T3
(pl)
*
|
2013-11-22 |
2019-12-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Lek wziewny
|
DK2897589T3
(en)
|
2013-11-22 |
2018-03-12 |
Teva Branded Pharmaceutical Prod R & D Inc |
Inhalable drug
|
US10716907B2
(en)
|
2014-05-07 |
2020-07-21 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
PL3139984T3
(pl)
|
2014-05-07 |
2021-11-08 |
Boehringer Ingelheim International Gmbh |
Nebulizator
|
ES2954961T3
(es)
|
2014-05-07 |
2023-11-27 |
Boehringer Ingelheim Int |
Unidad, nebulizador y método
|
US10034866B2
(en)
|
2014-06-19 |
2018-07-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Inhalable medicament comprising tiotropium
|
RU2577289C1
(ru)
*
|
2015-03-26 |
2016-03-10 |
Шолекс Девелопмент Гмбх |
Аэрозольный препарат на основе фенотерола гидробромида для лечения заболеваний органов дыхания
|
MX2019003097A
(es)
*
|
2016-09-19 |
2019-09-13 |
Mexichem Fluor Sa De Cv |
Composicion farmaceutica.
|
EP3569221A1
(en)
*
|
2018-05-17 |
2019-11-20 |
Notoxins IP B.V. |
Aqueous formulations comprising ipratropium for topical treatment of hyperhidrosis
|
WO2020152548A1
(en)
*
|
2019-01-24 |
2020-07-30 |
Glenmark Pharmaceuticals Limited |
Stable aerosol inhalation compositions of formoterol
|
GB2584686A
(en)
*
|
2019-06-11 |
2020-12-16 |
Mexichem Fluor Sa De Cv |
Methods
|
CN111297835B
(zh)
*
|
2019-12-20 |
2022-11-25 |
上海方予健康医药科技有限公司 |
含抗胆碱能药物的吸入气雾剂及其制备工艺和使用方法
|
CA3193038A1
(en)
*
|
2020-10-09 |
2022-04-14 |
Enrico Zambelli |
A pharmaceutical formulation for pressurised metered dose inhaler
|